KRAS G12C inhibitor 1
CAS No. 1698023-15-2
KRAS G12C inhibitor 1( —— )
Catalog No. M12589 CAS No. 1698023-15-2
A potent, selective, covalent KRAS G12C inhibitor that selectively inhibit KRAS G12C-dependent signaling and cancer cell growth at sub-micromolar concentrations.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameKRAS G12C inhibitor 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective, covalent KRAS G12C inhibitor that selectively inhibit KRAS G12C-dependent signaling and cancer cell growth at sub-micromolar concentrations.
-
DescriptionA potent, selective, covalent KRAS G12C inhibitor that selectively inhibit KRAS G12C-dependent signaling and cancer cell growth at sub-micromolar concentrations.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
TargetRas
-
RecptorRas
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1698023-15-2
-
Formula Weight396.85
-
Molecular FormulaC21H18ClFN4O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name1-(4-(6-chloro-7-(2-fluorophenyl)quinazolin-4-yl)piperazin-1-yl)prop-2-en-1-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zeng M, et al. Cell Chem Biol. 2017 Aug 17;24(8):1005-1016.e3.
molnova catalog
related products
-
XRP44X
XRP44X is a potent inhibitor of Ras-Net (Elk-3) pathway.
-
ZCL278
A potent, cell-permeable Cdc42-specific small-molecule inhibitor (Kd=6.4 uM).
-
ADT-007
ADT-007 is an orally active and selective pan-RAS inhibitor with potent anticancer activity.ADT-007 blocks GTP activation of RAS and MAPK/AKT signaling by binding to anucleotide RAS.ADT-007 is used in the study of gastrointestinal cancers.
Cart
sales@molnova.com